LanguageClose X

Jincheng medicine always will "continue to increase investment in science and technology, strengthen independent innovation, building science and technology competitiveness" as the center of the enterprise development strategy, increase the intensity of technology research and development, gradually realize the "improve the level of industry, expanding industries, optimize the product structure, improve the quality of running" development goals.

Company as a national high and new technology enterprise, national torch plan, in shandong province science and technology research project implementation unit, academician workstation, two provincial enterprise technology center and postdoctoral workstation, three professional laboratory, has acquired and is applying for nearly 40 national invention patents, to determine a batch of reserves as the focus in the future development of varieties of products.

At present, the company in accordance with the development plan formulated the "pharmaceutical industry chain in jincheng" direction "of the" three characteristics, namely by seeking the antibiotics industry merger and acquisition, the terminal building of cephalosporins antibiotics preparation industry chain; Through accelerating the Beijing longyi purchasing and merging project, the characteristic industrial chain of gynecology and regulating immunity preparations is constructed. By accelerating the expansion of biological companies, international cooperation and new drug research and development are carried out to realize industrial upgrading and build a polypeptide characteristic biopharmaceutical industry chain.

Jincheng medical school and enterprise based on a technology center of excellent platform combined advantage, improve the hardware and software configuration, strengthen the talent introduction and training, widely absorbs the domestic and foreign high level science and technology talents, build up a industry leading technology research and development team.

Company's existing technology research and development staff of 136 people, 112 professional researchers, including Dr 7 people, master's and senior title 58 people, build the multi-disciplinary, multilayer of professional talent team faces.

Company has two core institutions, experts committee and technical committee consists of technical center, institute of jinan university, zhejiang university joint research and development center, biological separation engineering room, process control and equipment engineering room and so on six professional laboratory, two pilot workshop and four big functions, including 1 national recognized enterprise technology center, 2 provincial engineering technology center and the present domestic only cephalosporin class and related intermediates professional scientific research institutions, advanced equipment, perfect facilities, has the abundant technical research and development strength.

Company always will "continue to increase investment in science and technology, promote scientific and technological innovation, building science and technology competitiveness" as the center of the enterprise development strategy, with high-end intermediates, characteristic and biological pharmaceutical apis for direction, each project to develop more new products, the implementation of a number of measures of reformation measures, technological level of each product in the same industry, the technology mature, stable quality, and set up relative cost advantage, there are a number of technological innovation for national patents and independent intellectual property rights, through the synthesis, separation technology, the integrated use of and development of biotechnology, make the product yield, quality, etc. To further improve the indicators, Process route green road.

Based on post-doctoral scientific research workstation, formed a provincial enterprise technology center and engineering technology research center, as a product development, technological innovation, technology import, digestion, absorption, talent cultivation and collection to release the important platform of industry information and market information, greatly improve the enterprise's capacity for independent innovation.

In pay attention to independent research and development at the same time, the company also strengthen external cooperation, and jinan university, tianjin university, shandong university, dalian university of technology, Shanghai institute of organic chemical synthesis, and other well-known institutions to carry out extensive exchanges and cooperation, reasonable combination of science and technology talents, optimize the allocation of resources, will, talent training and scientific research results into organic combination, make the company maintained a leading market competitiveness.

Company and jinan university jointly developed the "third generation cephalosporin antibiotic intermediates active ester key technology and industrialization" project won the "national science and technology progress second prize", and has a number of techniques for the national invention patent, the overall technology has reached the international advanced level, have to undertake and complete the high-tech industrialization demonstration project, key new product, the torch plan and other state-level science and technology and high technology industrialization projects, in order to promote the localization of China's high-end cephalosporin antibiotics and cephalosporin antibiotics industry technology progress, support the cephalosporin API of the world leading position in our country has made the important contribution.